Rani Therapeutics Holdings, Inc.RANINASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P9
Near historical low
vs 3Y Ago
-1.3x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -19.28% |
| Q2 2025 | -10.95% |
| Q1 2025 | 2.80% |
| Q4 2024 | -2.93% |
| Q3 2024 | -12.20% |
| Q2 2024 | 3.37% |
| Q1 2024 | 6.38% |
| Q4 2023 | -12.16% |
| Q3 2023 | -7.95% |
| Q2 2023 | 5.94% |
| Q1 2023 | -4.11% |
| Q4 2022 | -1.98% |
| Q3 2022 | 14.56% |
| Q2 2022 | 2.10% |
| Q1 2022 | 4.10% |
| Q4 2021 | -62.43% |
| Q3 2021 | 357.28% |
| Q2 2021 | 32.72% |
| Q1 2021 | 43.40% |
| Q4 2020 | 115.15% |
| Q3 2020 | -5.27% |
| Q2 2020 | -36.60% |
| Q1 2020 | 0.00% |